Header

UZH-Logo

Maintenance Infos

Successful memory response following a booster dose with a virosome-formulated hepatitis a vaccine delayed up to 11 years


Hatz, C; van der Ploeg, R; Beck, B R; Frösner, G; Hunter, M; Herzog, C (2011). Successful memory response following a booster dose with a virosome-formulated hepatitis a vaccine delayed up to 11 years. Clinical and Vaccine Immunology : CVI, 18(5):885-887.

Abstract

Boosting adult travelers with the virosome-formulated, aluminum-free hepatitis A vaccine Epaxal up to 128 months after a single primary dose confers full protection against hepatitis A, even in travelers aged 50 years and above. Delaying the booster dose did not influence the immune memory response to Epaxal.

Abstract

Boosting adult travelers with the virosome-formulated, aluminum-free hepatitis A vaccine Epaxal up to 128 months after a single primary dose confers full protection against hepatitis A, even in travelers aged 50 years and above. Delaying the booster dose did not influence the immune memory response to Epaxal.

Statistics

Citations

18 citations in Web of Science®
20 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

1 download since deposited on 11 Nov 2011
0 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Epidemiology, Biostatistics and Prevention Institute (EBPI)
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2011
Deposited On:11 Nov 2011 07:33
Last Modified:07 Dec 2017 09:34
Publisher:American Society for Microbiology
ISSN:1556-679X
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1128/CVI.00358-10
PubMed ID:21411599

Download